SEC Form 4 · accession 0001179110-15-006565
CymaBay Therapeutics, Inc. · CBAY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert James Wills
Director
Period of report
Apr 16, 2015
Accepted (ET)
Apr 24, 2015 · 3:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001042074
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $5.90 | Apr 16, 2015 | A | 18,000 | A | — | Apr 15, 2025 | Common Stock | 18,000 | 18,000 | D |
Explanation of responses
- F1The option vests in 12 equal monthly installments with the vesting start date of March 18, 2015.